Respiratory diseases are leading causes of death and disability globally, with about 65 million people suffering from COPD, and 334 million from asthma, the most common chronic disease. Each year, tens of millions of people develop and can die from respiratory infections such as pneumonia and TB. Systemic inflammation may induce and exacerbate local inflammatory diseases in the lungs, and local inflammation can in turn cause systemic inflammation. There is increasing evidence of the coexistence of systemic and local inflammation in patients suffering from asthma, COPD, and other lung diseases, and the co-morbidity of two or more local inflammatory diseases often occurs. For example, rheumatoid arthritis frequently occurs together with, and promotes the development of, pulmonary hypertension. This co-morbidity significantly impacts quality of life, and can result in death for those affected. Current treatment options for lung diseases are neither always effective, nor often condition-specific; there is a desperate need for novel therapeutics in the field. Additionally, the molecular and physiological significance of most major lung diseases are not well understood, which further impedes development of new treatments, especially in the case of coexistent lung diseases with other inflammatory diseases. Great progress has been made in recent years in many areas of the field, particularly in understanding the molecular geneses, regulatory mechanisms, signalling pathways, and cellular processes within lung diseases, as well as basic and clinical technology, drug discovery, diagnoses, treatment options, and predictive prognoses. This is the first text to aggregate these developments. In two comprehensive volumes, experts from all over the world present state-of-the-art advances in the study of lung inflammation in health and disease. Contributing authors cover well-known as well as emerging topics in basic, translational, and clinical research, with the aim of providing researchers, clinicians, professionals, fellows, and students with new perspectives and concepts. The editor hopes this book will also help to direct future research in lung disease and other inflammatory diseases, and result in the development of novel therapeutics.
When we started the fieldwork, Radio Control Room staff were dedicated to working with one geographical area. They knew the patch and they also knew the ...
See letter from J. Smart to R. Gibson, 11 February 1948, RG109, vol. 409, file WLU.266-1, PAC. 168 Letter from Gibson to Callison, 25 March 1949, RG109, vol. 409, file VVLU.266-1, PAC.
The last ethical issue, the fifth group, is inheritable genetic modification (IGM), which is a procedure used to modify genes along the germ lines that are transmitted to offspring (Frankel, 2003). Stem-cell research could help prevent ...
He is principally remembered today for his plays. FURTHER READING Becker, Lucille Frackman. Henry de Montherlant: A Critical Biography. Carbondale: Southern Illinois University Press, 1970. Gerrard, Charlotte Frankel.
This book examines the national security and preparedness issues, developments and analyses facing the U.S. today.
The primary objective in this study is to collate knowledge of species responses to single and multiple stressors into an Aquatic Species Physiological Limits (ASPL) database, which will be updated over time.
... the month of Ramadaan was enjoined in Sha'baan 2 AH, and that the Prophet (peace and blessings of Allaah be upon him) fasted nine Ramadaans, because he (peace and blessings of Allaah be upon him) died in Rabee' al-Awwal 11 AH.
A schoolteacher on Prince Edward Island falls in love with a beautiful reclusive girl who plays the violin exquisitely, but is mysteriously unable to speak.
This collected edition of the hit mini-series reveals Kirsty's first days in Hell, and how the road there is always paved with good intentions.
本书包括现代营销新观念,市场分析,市场营销环境,市场调查,市场预测,消费者行为研究,市场细分化战略,名牌战略等内容。